Elon Musk reposts a tweet, with Dave Lee suggesting Tesla leverage Cybercab experience to launch AI-driven consumer vehicles
Elon Musk reposted a tweet, with Dave Lee suggesting Tesla leverage Cybercab experience to launch AI-driven consumer vehicles. Lee stated that Cybercab marks a new line in the sand for Tesla, as previous vehicles were primarily designed for human driving, while Cybercab and subsequent models are engineered from the ground up for AI driving, prioritizing passenger comfort, peace, and entertainment. He added that technologies like Cybercab's “unboxed approach,” RIM plastic outer shell, brake-by-wire, and next-gen drivetrain, thermal management, and electronics can be utilized for cheaper, more efficient, and reliable next-generation consumer vehicles, including 4-5 passenger and 6-7 passenger Cybercab derivatives, as well as small sedans, CUVs, mid-size sedans and SUVs, and large SUVs.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Oracle, Meta, and SpaceX credit default swaps (CDS) hit all-time highs, as the market anticipates a surge in AI-related bond issuance in Q4.
-
2
Liu Jun, President of Industrial and Commercial Bank of China (ICBC): Commercial Banks Bear Heavier Financial and Legal Responsibilities Than Central Banks in AI Deployment
-
3
Bain Survey: Chinese Consumers Prioritize Technology in Car Purchases, While Europeans and Americans Still Value Price; Western Automakers Face Dual Pressure
-
4
Anthropic pitches AI safety bill that would require judge's permission to block models
-
5
Anthropic reportedly faces a compute shortage as cloud giants view it as a competitor, plans November IPO.
-
6
Media reports: Amazon Web Services (AWS) has billions of dollars worth of NVIDIA chips backlogged in its warehouses due to power shortages, leading to negative free cash flow.
-
7
NextDC's data center project in Australia faces power supply delays due to resident protests, leading to a more than one-third reduction in its FY2027 earnings guidance and a 45% plunge in its stock price.
-
8
Hansoh Pharmaceutical inks up to $15B drug deal with Roche, China's innovative drug out-licensing hits $130B
-
9
King Charles III of the UK praised Oman's peaceful efforts in reopening the Strait of Hormuz.
-
10
U.S. equity index futures rose, boosted by strong earnings reports from AI-related companies.
Markets Today
Recommended Reading


